Systematic review of survey/questionnaire-based drug utilization studies in Turkiye Türkiye’de yapılmış ilaç kullanımı anket çalışmalarının analizi ve sistematik incelemes


Gultekin O., HASPOLAT N., Cicek B., Havyarimana D., AKICI A., AYDIN V.

Northern Clinics of Istanbul, cilt.11, sa.6, ss.525-533, 2024 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 6
  • Basım Tarihi: 2024
  • Doi Numarası: 10.14744/nci.2024.60252
  • Dergi Adı: Northern Clinics of Istanbul
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Central & Eastern European Academic Source (CEEAS), Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.525-533
  • Anahtar Kelimeler: Drug utilization studies, pharmacoepidemiology, questionnaire, survey, systematic review
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Drug utilization studies (DUS), providing insights into various aspects of pharmacoepidemiology from prescrib-ing to medication use, can be conducted through real-world data from health records and survey-based data. In this study, we aimed to describe survey/questionnaire-based DUS conducted in Turkiye. METHODS: We searched online databases for the most frequently used keywords in DUS from January 1993 till May 2023 and identified 180 survey-based DUS conducted in Turkiye. We described DUS by their populations, sociodemographic characteristics, timeframe, setting and provinces, data collection method, medication categories, and article-specific variables were evaluated. RESULTS: We identified that 68.3% of the DUS were in English and 91.7% were indexed in Web of Science (median 1 [interquartile range: 1–2] citation). We found that 21.7% of the articles (n=39) had pharmacology affiliation. Adults are the target population in 37.8% of the studies and age and gender were not reported in 27.2% and 16.7%, respectively. The response rate was not stated in 55.0%. We determined that 48.3% of the studies were focused on a single medication/ medication group. The mean time from data collection to publication was 2.5±1.9 years, and the highest number of articles (10.6%) were published in 2021. CONCLUSION: Our systematic review shows that the majority of DUS were listed in well-known international indices, suggesting that our local studies invoke global interest and hold a valuable position in health research. Nevertheless, lack of reporting of methodological characteristics in substantial part of the studies can be considered an important room for improvement of DUS.